The GABABreceptor as a target for antidepressant drug action
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Preclinical and clinical data suggest that a modification in GABA B receptor expression and function may contribute to the symptoms of major depression and the response to antidepressants. This includes laboratory animal experiments demonstrating that antidepressants modify brain GABA B receptor expression and function and that GABA B receptor antagonists display antidepressant potential in animal models of this condition. Clinical and post‐mortem studies reveal changes in GABAergic transmission associated with depression as well as depression‐related changes in GABA B subunit expression that are localized to the cortical depression network. Detailed in this review are the preclinical and clinical data implicating a role for the GABA B receptor system in mediating symptoms of this disorder and its possible involvement in the response to antidepressants. Particular emphasis is placed on clinical and post‐mortem studies, including previously unpublished work demonstrating regionally‐selective modifications in GABA B receptor subunit expression in brain samples obtained from depressed subjects. Together with the earlier preclinical studies, these new data point to a role for the GABA B system in major depression and support the antidepressant potential of GABA B receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 8×
“, 2009), it is possible that alterations in GABAB receptor expression and function influences hippocampal neurogenesis, which may be a component of the clinical response to antidepressants (Pittenger and Duman, 2008).”
BackgroundInfluentialSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 2×
“The brain areas examined were the hippocampus, subgenual cingulate and orbitofrontal cortex, regions implicated in the pathophysiology of depression (Sheline, 1996; Sheline et al., 1999; Mayberg, 2003; Seminowicz et al., 2004; Pittenger and Duman, 2008; Hajszan et al., 2009; Koolschijn et al., 2009; Yucel et al., 2009…”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 2×
“During that time, neuronal pathways and neurochemical systems that appear critical for mediating the symptoms of this disorder have been identified (Rajkowska et al., 1999; Nestler et al., 2001; Krystal et al., 2002; Mayberg, 2003; Seminowicz et al., 2004).”
BackgroundSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 3×
“The brain areas examined were the hippocampus, subgenual cingulate and orbitofrontal cortex, regions implicated in the pathophysiology of depression (Sheline, 1996; Sheline et al., 1999; Mayberg, 2003; Seminowicz et al., 2004; Pittenger and Duman, 2008; Hajszan et al., 2009; Koolschijn et al., 2009; Yucel et al., 2009…”
BackgroundMayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166 · cited 4×
“During that time, neuronal pathways and neurochemical systems that appear critical for mediating the symptoms of this disorder have been identified (Rajkowska et al., 1999; Nestler et al., 2001; Krystal et al., 2002; Mayberg, 2003; Seminowicz et al., 2004).”
BackgroundInfluentialKoolschijn, P. C. M. P., van Haren, N. E. M., Lensvelt‐Mulders, G. J. L. M., Hulshoff Pol, H. E., & Kahn, R. S. (2009) · Human Brain Mapping · doi:10.1002/hbm.20801 · Cited by 902
Limbic-frontal circuitry in major depression: a path modeling metanalysis
Seminowicz, D. A., Mayberg, H. S., McIntosh, A. R., Goldapple, K., Kennedy, S., Segal, Z., & Rafi-Tari, S. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.015 · Cited by 710
Cited by
The GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Kumar, K., Sharma, S., Kumar, P., & Deshmukh, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.003 · Cited by 125
Meditation-Related Increases in GABAB Modulated Cortical Inhibition
Guglietti, C. L., Daskalakis, Z. J., Radhu, N., Fitzgerald, P. B., & Ritvo, P. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.08.005 · Cited by 83
Metadata
- Authors
- Ghose, S., Winter, M. K., McCarson, K. E., Tamminga, C. A., & Enna, S. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-12-06
- Volume
- 162
- Issue
- 1
- Pages
- 1-17
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1528823084
- Cited by
- 86
- References
- 17
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The GABABreceptor as a target for antidepressant drug action. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.01004.x
- The paper
- Ghose, S., Winter, M. K., McCarson, K. E., Tamminga, C. A., & Enna, S. J. (2011). The GABABreceptor as a target for antidepressant drug action. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.01004.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.